Retno Wahyuningsih,Lecturer at the University of Indonesia and Christian University of Indonesia, Faculty of Medicine Email
Fungal burden of disease in Indonesia: Now published 2021; View poster from ISHAM 2015, view slide presentation.
How you have helped GAFFI: By estimating fungal burden in my country (Indonesia), by doing research on mycotic diseases, active in medical mycology organization in Indonesia and Asia Pacific
Personal comment on the major needs in Indonesia which GAFFI should be addressing: Diagnostic laboratory for mycotic diseases is very limited. It is necessary to develop a program to disseminate that capabilities. To improve doctor’s awareness to mycotic diseases would be very helpful. In addition, antifungal availability is also limited.
Links to key fungal/global health institutions: Perhimpunan Mikologi Kedokteran Indonesia (PMKI)/Indonesian Society for Human and Animal Mycology (INSHAM) http://www.pmki.or.id
Anna Rozaliyani, Head of Dept. of Parasitology, Faculty of Medicine, Universitas Indonesia, Jakarta, - Chairperson of Indonesian Society of Respirology (ISR), Jakarta Chapter - Coordinator of Indonesia Pulmonary Mycoses & Fungal Culture Collection (IPMC & FCC), Jakarta. Email
How you have helped GAFFI: Together with our colleagues in Indonesia, we have promoted diagnosis and management of fungal diseases in Indonesia. - We carried out several studies on aspergillosis, pneumocystosis, and other pulmonary mycoses in Indonesia that have been published. - We conducted the first multi-centre study in Jakarta established the incidence of invasive pulmonary aspergillosis (IPA) in the ICU patients (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6402463/). - One of our paper attempts to increase awareness of fungal diseases in Indonesia (https://jurnalrespirologi.org/index.php/jri/article/view/69/0). - We have succeeded in conducting workshops and seminars on fungal disease as collaboration amongst Indonesian Society of Respirology (ISR), Indonesia Pulmonary Mycoses Centre (IPMC), Indonesian Ministry of Health, and other stakeholders.
Personal comment on the major needs in Indonesia which GAFFI should be addressing: - Fostering the establishment of the mycology reference laboratories in major provinces in Indonesia. - Developing national guidelines on diagnosis and management of fungal diseases in Indonesia, including invasive candidiasis, aspergillosis, mucormycosis, histoplasmosis, etc. - Encouraging government and key institutions policies related to fungal diagnostics access and antifungal agents availability for patients
Links to key fungal/global health institutions: • Indonesia Pulmonary Mycoses Centre https://mikologi.or.id • Parasitology Laboratory, Faculty of Medicine Universitas Indonesia https://www.parasitologiklinikindonesia.org • The Indonesian Society of Respirology https://www.klikpdpi.com